Atlas Trials

EBV-associated Malignancies

3 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch EBV-associated Malignancies

RecordFirmDate
Therapeutic Effects of Epstein-Barr Virus Immune T-Lymphocytes Derived From a Normal HLA-Compatible Or Partially-Matched Third-Party Donor in the Treatment of EBV Lymphoproliferative Disorders and EBV-Associated Malignancies (NCT01498484)Atara Biotherapeutics2011-12-01
Biological Therapy in Treating Patients at High-Risk or With Lymphoma, Lymphoproliferative Disease, or Malignancies (NCT00002663)Atara Biotherapeutics1995-03-01

Track EBV-associated Malignancies automatically

Every clearance here is in the API, with alerts when new ones post.